TCL Archive NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality April 26, 1974
TCL Archive In Brief: NCI Terminates Straus’ Grant Following Site Visit Report Charging “Lack Of satisfactory Progress February 19, 1982
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006